Travere Therapeutics (NasdaqGM:TVTX) Q3 2026 Earnings call November 02, 2026 04:30 PM ET Company ParticipantsEric Dube - President and CEOPeter Heerma - Chief Commercial OfficerJula Inrig - Head of R&D and Chief Medical OfficerChris Cline - CFOLaura Chico - Managing Director, Co-Head of Healthcare ResearchJoe Schwartz - Managing DirectorGavin Clark-Gartner - Managing DirectorPrakhar Agrawal - Managing DirectorSadia Rahman - Vice PresidentAlex Thompson - Research Managing DirectorVamil Divan - Managing Direc ...